News
FORBES | When Clinical Trials Are Marketing Ploys, Not Science
Bioethicists from McGill University’s Biomedical Ethics Unit published a piece this week in the Journal of the American Medical Association’s JAMA Internal Medicine, suggesting that some post-approval clinical trials may even promote the use of ineffective and costly off-label usage.
